[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-367150-105":59,"doc-detail-367150-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","multifunctional-molecular-hybrid-for-targeted-colorectal-cancer-cells-integrating-doxorubicin-as1411-aptamer-and-t9u4-aso","Multifunctional molecular hybrid for targeted colorectal cancer cells - Integrating doxorubicin, AS1411 aptamer, and T9/U4 ASO","","Colorectal cancer (CRC) presents a major global health burden, while existing therapies often damage both malignant and healthy cells. A multifunctional drug delivery platform was designed as a single molecular hybrid combining bioactive components, the anticancer agent doxorubicin, the AS1411 aptamer, and the T9/U4 ASO to control SW480 cell proliferation. AS1411 targets nucleolin, enriched on cancer cell membranes, and T9/U4 ASO suppresses human telomerase RNA activity to further restrain growth. The hybrid was synthesized via oligonucleotide hybridization, then doxorubicin loading and cellular evaluation. Binding was confirmed by fluorescence microscopy and flow cytometry, with selective recognition linked to nucleolin availability. The doxorubicin-loaded system showed encapsulation, reduced toxicity, decreased hTERT and vimentin expression, and apoptosis modulation, including reduced Bcl-2 and increased Bax.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/multifunctional-molecular-hybrid-for-targeted-colorectal-cancer-cells-integrating-doxorubicin-as1411-aptamer-and-t9u4-aso/367150/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/multifunctional-molecular-hybrid-for-targeted-colorectal-cancer-cells-integrating-doxorubicin-as1411-aptamer-and-t9u4-aso/367150.png","ImageObject",300,407,{"name":92,"@type":93},"Aria","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What components are integrated into the multifunctional molecular hybrid?","Question",{"text":112,"@type":113},"The hybrid integrates doxorubicin, the AS1411 aptamer, and the T9/U4 ASO to target and inhibit cancer cell proliferation.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does AS1411 aptamer contribute to targeting colorectal cancer cells?",{"text":117,"@type":113},"AS1411 binds nucleolin, which is overexpressed on colorectal cancer cell membranes, enabling specific recognition of SW480 cells.",{"name":119,"@type":110,"acceptedAnswer":120},"What evidence supports selective binding and functional activity of the hybrid?",{"text":121,"@type":113},"Fluorescence microscopy and flow cytometry demonstrate specific recognition of SW480 cells, and doxorubicin-loaded constructs show anti-proliferative effects with molecular changes linked to apoptosis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},367150,1790308018,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","PLOS ONE  \nOPEN ACCESS  \nCitation: Jiramitmongkon K, Rotkrua P, Khanchaitit P, Arunpanichlert J, Soontornworajit B (2025) Multifunctional molecular hybrid for targeted colorectal cancer cells: Integrating doxorubicin, AS1411 aptamer, and T9/U4 ASO. PLoS ONE 20(2): e0317559 . [https://doi.org/10.1371/journal](https://doi.org/10.1371/journal). pone.0317559  \nEditor: Bing Xu, Brandeis University, UNITED STATES OF AMERICA  \nReceived: October 1, 2024  \nAccepted: December 31, 2024  \nPublished: February 13, 2025  \nPeer Review History: PLOS recognizes the benefits of transparency in the peer review process; therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. The editorial history of this article is available here:  \n[https://doi.org/10.1371/journal.pone.0317559](https://doi.org/10.1371/journal.pone.0317559)  \n[Copyright:](Copyright:) © [2025 Jiramitmongkon](2025 Jiramitmongkon) et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  \nData Availability Statement: Minimal data sets are available in figshare repository: DOI 10.6084/m9 . figshare.27924438.  \nRESEARCH ARTICLE  \nMultifunctional molecular hybrid for targeted colorectal cancer cells: Integrating doxorubicin, AS1411 aptamer, and T9/U4 ASO  \nKanpitcha Jiramitmongkon1,2,3, Pichayanoot Rotkrua3,4, Paisan Khanchaitit2, Jiraporn Arunpanichlert1,3, Boonchoy Soontornworajit1,3 *  \n1 Faculty of Science and Technology, Department of Chemistry, Thammasat University, Pathumthani, Thailand, 2 National Nanotechnology Center, National Science and Technology Development Agency, Thailand Science Park, Pathumthani, Thailand, 3 Thammasat University Research Unit in Innovation of Molecular Hybrid for Biomedical Application, Pathumthani, Thailand, 4 Faculty of Medicine, Department of Preclinical Science, Division of Biochemistry, Thammasat University, Pathumthani, Thailand  \n* [sbooncho@tu.ac.th](sbooncho@tu.ac.th)  \nAbstract  \nColorectal cancer (CRC) poses a global health challenge, with current treatments often harming both cancerous and normal cells. To improve efficacy, a multifunctional drug delivery platform has been developed, integrating bioactive materials, anticancer agents, and targeted recognition ligands into a single molecule. This study aimed to create a molecular hybrid (MH) containing doxorubicin, AS1411 aptamer, and T9/U4 ASO to regulate SW480 cell proliferation. The AS1411 aptamer targets nucleolin, overexpressed on cancer cell membranes, while T9/U4 ASO inhibits human telomerase RNA activity, further hindering cancer cell proliferation. AS-T9/U4_MH was synthesized via oligonucleotide hybridization, followed by doxorubicin loading and evaluation of its impact on cell proliferation. Binding capability of this MH was verified using fluorescence microscopy and flow cytometry, demonstrating specific recognition of SW480 cells due to nucleolin availability on the cell surface. These findings were corroborated by both microscopy and flow cytometry. AS-T9/ U4_MH exhibited anti-proliferative effects, with the doxorubicin-loaded system demonstrating encapsulation and reduced toxicity. Moreover, the presence of Dox within AS-T9/ U4_MH led to a notable reduction in hTERT and vimentin expression in SW480 cells. Additionally, examination of apoptotic pathways unveiled a marked decrease in Bcl-2 expression and a simultaneous increase in Bax expression in SW480 cells treated with Dox-loaded AST9/U4_MH, indicating its impact on promoting apoptosis. This molecular hybrid shows promise as a platform for integrating chemotherapeutic drugs with bioactive materials for cancer therapy.  \nIntroduction  \nTo improve the efficacy of anti-cancer drugs, multifunctional drugs have been developed. These agents combine theranostic capabilities, ","cbCaijvlLbM0Llqo","https://ap.wps.com/l/cbCaijvlLbM0Llqo","pdf",3558249,22,"English","# Abstract\n# Introduction","[{\"question\":\"What components are integrated into the multifunctional molecular hybrid?\",\"answer\":\"The hybrid integrates doxorubicin, the AS1411 aptamer, and the T9/U4 ASO to target and inhibit cancer cell proliferation.\"},{\"question\":\"How does AS1411 aptamer contribute to targeting colorectal cancer cells?\",\"answer\":\"AS1411 binds nucleolin, which is overexpressed on colorectal cancer cell membranes, enabling specific recognition of SW480 cells.\"},{\"question\":\"What evidence supports selective binding and functional activity of the hybrid?\",\"answer\":\"Fluorescence microscopy and flow cytometry demonstrate specific recognition of SW480 cells, and doxorubicin-loaded constructs show anti-proliferative effects with molecular changes linked to apoptosis.\"}]","Multifunctional molecular hybrid for targeted colorectal cancer cells - Integrating doxorubicin, AS1411 aptamer, and T9/U4 ASO | PDF",1790169503,55,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/56036f5bd3410592ff8c87c633c44785.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e5fcb3539614ad270a214513ca1ce0ed.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/07e1ef270e4b18b532b8395b87228d2e.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a18fdc5f57fdc36ce87dc81cbad03af8.webp",980,1268]